Literature DB >> 18460471

The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly.

Raffaella Toso1, Hua Zhu, Rodney M Camire.   

Abstract

Zymogens of the chymotrypsin-like serine protease family are converted to the protease state following insertion of a newly formed, highly conserved N terminus. This transition is accompanied by active site formation and ordering of several surface loops in the catalytic domain. Here we show that disruption of this transition in factor X through mutagenesis (FXa(I16L) and FXa(V17A)) not only alters active site function, but also significantly impairs Na(+) and factor Va binding. Active site binding was improved in the presence of high NaCl or with saturating amounts of factor Va membranes, suggesting that allosteric linkage exists between these sites. In line with this, irreversible stabilization of FXa(I16L) with Glu-Gly-Arg-chloromethyl ketone fully rescued FVa binding. Furthermore, the K(m) for prothrombin conversion with the factor Xa variants assembled into prothrombinase was unaltered, whereas the k(cat) was modestly reduced (3- to 4-fold). These findings show that intramolecular activation of factor X following the zymogen to protease transition not only drives catalytic site activation but also contributes to the formation of the Na(+) and factor Va binding sites. This structural plasticity of the catalytic domain plays a key role in the regulation of exosite expression and prothrombinase assembly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460471      PMCID: PMC2441561          DOI: 10.1074/jbc.M802205200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase.

Authors:  Sai K Buddai; Larisa Toulokhonova; Peter W Bergum; George P Vlasuk; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2002-05-14       Impact factor: 5.157

2.  Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.

Authors:  A R Rezaie
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

3.  Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

Authors:  P Kuzmic
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

4.  The factor VII zymogen structure reveals reregistration of beta strands during activation.

Authors:  C Eigenbrot; D Kirchhofer; M S Dennis; L Santell; R A Lazarus; J Stamos; M H Ultsch
Journal:  Structure       Date:  2001-07-03       Impact factor: 5.006

5.  Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding.

Authors:  M C Underwood; D Zhong; A Mathur; T Heyduk; S P Bajaj
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

7.  Autoantibody against prothrombin aberrantly alters the proenzyme to facilitate formation of a complex with its physiological inhibitor antithrombin III without thrombin conversion.

Authors:  S Madoiwa; Y Nakamura; J Mimuro; S Furusawa; T Koyama; T Sugo; M Matsuda; Y Sakata
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

8.  Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide.

Authors:  R M Camire; P J Larson; D W Stafford; K A High
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

9.  Definition of a factor Va binding site in factor Xa.

Authors:  A E Rudolph; R Porche-Sorbet; J P Miletich
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

10.  Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.

Authors:  Rodney M Camire
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

View more
  15 in total

1.  Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

Authors:  Mettine H A Bos; Michael Boltz; Liam St Pierre; Paul P Masci; John de Jersey; Martin F Lavin; Rodney M Camire
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

2.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

3.  Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity.

Authors:  Benjamin J Samelson-Jones; Jonathan D Finn; Lindsey A George; Rodney M Camire; Valder R Arruda
Journal:  JCI Insight       Date:  2019-06-20

4.  A rapid pro-hemostatic approach to overcome direct oral anticoagulants.

Authors:  Nabil K Thalji; Lacramioara Ivanciu; Robert Davidson; Phyllis A Gimotty; Sriram Krishnaswamy; Rodney M Camire
Journal:  Nat Med       Date:  2016-07-25       Impact factor: 53.440

5.  Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity.

Authors:  Lacramioara Ivanciu; Rodney M Camire
Journal:  Blood       Date:  2015-04-20       Impact factor: 22.113

Review 6.  Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

Authors:  Nabil K Thalji; Rodney M Camire
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

7.  Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro.

Authors:  Matthew W Bunce; Raffaella Toso; Rodney M Camire
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

8.  An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Authors:  Sai K Buddai; Juliana M Layzer; Genmin Lu; Christopher P Rusconi; Bruce A Sullenger; Dougald M Monroe; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.

Authors:  A von Drygalski; T J Cramer; V Bhat; J H Griffin; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

Review 10.  Procoagulant adaptation of a blood coagulation prothrombinase-like enzyme complex in australian elapid venom.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  Toxins (Basel)       Date:  2010-06-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.